Graf Akcie ANAB (AnaptysBio Inc). Diskuze k akciím ANAB. Aktuální informace ANAB.

Základní informace o společnosti AnaptysBio Inc (Akcie ANAB)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 790.42M
Hodnota podniku (EV) 350.95M
Tržby 101.274M
EBITDA -8.57
Zisk -8.71
Růst v tržbách Q/Q N/A %
Růst v tržbách Y/Y N/A %
P/E (Cena vůči ziskům) N/A
Forward P/E -44.92
EV/Sales 3.47
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 7.80
P/FCF 147.11
Price/Book 1.99
Účetní hodnota na akcii 14.21
Hotovost na akcii 14.10
FCF vůči ceně 0.68 %
Počet zaměstnanců 94
Tržba na zaměstnance 1077000
Profit margin -26.57 %
Operating margin -9.76 %
Gross margin 100.00 %
EBIT margin -8.60 %
EBITDA margin -8.46 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -97.47 %
EPS - Očekávaný růst příští rok 1.15 %
Return on assets -2.15 %
Return on equity -2.29 %
ROIC -4.68 %
ROCE -2.15 %
Dluhy/Equity 0.05
Čistý dluh/EBITDA 173.07
Current ratio 19.31
Quick Ratio 19.31
Volatilita 4.47
Beta 0.50
RSI 58.24
Cílová cena analytiků 28
Známka akcie (dle analytiků) 2.67
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 27.433M
Procento shortovaných akcií 19.77 %
Short ratio 15.73 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2017
Země United States

Finanční výsledky akcie ANAB

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$8$5$10$16.684$17.571$15.838$5.483
Cost Of Goods Sold-------
Gross Profit$8$5$10$16.684$17.571$15.838$5.483
Research And Development Expenses$99.338$56.196$29.443$15.419$17.304$8.614$8.82
SG&A Expenses$16.094$15.526$9.338$4.29$3.589$2.354$1.95
Other Operating Income Or Expenses-------
Operating Expenses$115.432$71.722$38.781$19.709$20.893$10.968$10.77
Operating Income$-107.432$-66.722$-28.781$-3.025$-3.322$4.87$-5.287
Total Non-Operating Income/Expense$9.944$4.874$-1.289$-1.234$-1.944$-1.338$-0.258
Pre-Tax Income$-97.488$-61.848$-30.07$-4.259$-5.266$3.532-
Income Taxes$-0.152$-0.192--$0.139--
Income After Taxes$-97.336$-61.656$-30.07$-4.259$-5.405$3.532$-5.545
Other Income-------
Income From Continuous Operations$-97.336$-61.656$-30.07$-4.259$-5.405$3.532$-5.545
Income From Discontinued Operations-------
Net Income$-97.336$-61.656$-30.07$-4.259$-5.405$0.232$-5.545
EBITDA$-106.918$-66.407$-28.598$-2.792$-3.048$5.178$-4.707
EBIT$-107.432$-66.722$-28.781$-3.025$-3.322$4.87$-5.287
Basic Shares Outstanding2725203328
Shares Outstanding2725203328
Basic EPS$-3.60$-2.50$-1.52$-1.62$-2.12$0.09$-0.71
EPS - Earnings Per Share$-3.60$-2.50$-1.52$-1.62$-2.12$0.09$-0.71
# 2020 2019 2018 2017 2016 2015
Current Ratio12.789319.885317.934410.19767.24842.0889
Long-term Debt / Capital--0.0240.26020.10380.4444
Debt/Equity Ratio0.00340.01560.04690.35170.11580.7998
Gross Margin100100100100100100
Operating Margin-1342.9-1334.44-287.81-18.1311-18.906230.7488
EBIT Margin-1342.9-1334.44-287.81-18.1311-18.906230.7488
EBITDA Margin-1336.475-1328.14-285.98-16.7346-17.346832.6935
Pre-Tax Profit Margin-1218.6-1236.96-300.7-25.5275-29.969822.3008
Net Profit Margin-1216.7-1233.12-300.7-25.5275-30.76091.4648
Asset Turnover0.01840.00980.03040.26830.31220.6319
Inventory Turnover Ratio------
Receiveable Turnover-28.73566.24613.122614.33210.8852
Days Sales In Receivables-12.70258.4365116.890125.467533.5317
ROE - Return On Equity-24.0331-12.6769-9.776311.135215.3643-11.4545
Return On Tangible Equity-24.0331-12.6769-9.7763-10.846-12.766658.9354
ROA - Return On Assets-22.366-12.1132-9.1297-6.8495-9.603814.0914
ROI - Return On Investment-24.0331-12.6769-9.542-8.0242-11.441632.7462
Book Value Per Share14.8618.065712.928514.812516.09772.4156
Operating Cash Flow Per Share-0.6031-0.98342.44170.3758-9.6866.6302
Free Cash Flow Per Share-0.5898-1.01172.4460.4501-9.72296.5786

Porovnání s konkurencí: Akcie ANAB

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
ANAB N/A N/A N/A % 1.15 % -2.29 % 1.99 -26.57 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %
Akcie OCUL 0.00 N/A 344.51 % 19.05 % -174.71 % 11.57 -894.31 %

Nedávné obchody insiderů: Akcie ANAB

Jméno Obchod Cena Objem
Hamza Suria
President and CEO
Option
14 Jan 2019
$1.12 $44,800
Marco Londei
Chief Medical Officer
Option
15 Jan 2019
$6.93 $132,190
Hamza Suria
President and CEO
Option
17 Apr 2019
$1.12 $11,200
Marco Londei
Chief Medical Officer
Option
4 Jun 2019
$0.70 $7,042
Hamza Suria
President and CEO
Prodej
10 Jun 2019
$73.76 $1,654,289
Hamza Suria
President and CEO
Option
22 Nov 2019
$1.12 $11,200
Marco Londei
Chief Medical Officer
Option
27 Nov 2019
$6.93 $320,180
J. Anthony Ware
Director
Nákup
10 Dec 2019
$14.05 $50,580
Hamza Suria
President and CEO
Option
5 Feb 2020
$1.12 $11,200
Hamza Suria
President and CEO
Option
10 Mar 2020
$1.12 $11,200
Eric J Loumeau
COO and General Counsel
Option
10 Feb 2021
$14.02 $140,200

Diskuze k akciím ANAB